Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis

• Published in: PloS one Vol. 11; no. 9; p. e0162099
• Main Authors: Zongyi, Yin, Dongying, Chen, Baifeng, Li
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 09-09-2016; Public Library of Science (PLoS)
• Subjects: Analysis; Animals; Autoimmunity; Bibliometrics; Biology and life sciences; Cells (Biology); Citation indexes; Computer and Information Sciences; Documents; Foxp3 protein; Gene expression; Gene therapy; Granzyme B; Growth rate; Helper cells; Hematology; Homeostasis; Hot spots; Humans; Immunology; Immunotherapy; Keywords; Lymphocytes; Lymphocytes T; Medicine and health sciences; Research and Analysis Methods; Scientometrics; T cells; T-Lymphocytes, Regulatory; Transplants & implants
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0162099

We aimed to analyze the global scientific output of regulatory T-cell (Treg) research and built a model to qualitatively and quantitatively evaluate publications from 2000 to 2015. Data were obtained from the Web of Science Core Collection (WoSCC) of Thomson Reuters on January 1, 2016. The bibliometric method and Citespace III were used to analyze authors, journals, publication outputs, institutions, countries, research areas, research hotspots, and trends. In total, we identified 35,741 publications on Treg research from 2000 to 2015, and observed that the annual publication rate increased with time. The Journal of Immunology published the highest number of articles, the leading country was the USA, and the leading institute was Harvard University. Sakaguchi, Hori, Fontenot, and Wang were the top authors in Treg research. Immunology accounted for the highest number of publications, followed by oncology, experimental medicine, cell biology, and hematology. Keyword analysis indicated that autoimmunity, inflammation, cytokine, gene expression, foxp3, and immunotherapy were the research hotspots, whereas autoimmune inflammation, gene therapy, granzyme B, RORγt, and th17 were the frontiers of Treg research. This bibliometric analysis revealed that Treg-related studies are still research hotspots, and that Treg-related clinical therapies are the research frontiers; however, further study and collaborations are needed worldwide. Overall, our findings provide valuable information for the editors of immunology journals to identify new perspectives and shape future research directions.